HALOZYME THERAPEUTICS INC's ticker is and the CUSIP is 40637HAD1. A total of 49 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $240,210 | +33.7% | 283,000 | +31.6% | 0.00% | – |
| Q2 2023 | $179,647 | -2.0% | 215,000 | 0.0% | 0.00% | – |
| Q1 2023 | $183,289 | -12.4% | 215,000 | 0.0% | 0.00% | – |
| Q4 2022 | $209,222 | -5.8% | 215,000 | -17.6% | 0.00% | – |
| Q3 2022 | $222,000 | -4.3% | 261,000 | 0.0% | 0.00% | – |
| Q2 2022 | $232,000 | +46.8% | 261,000 | +45.0% | 0.00% | – |
| Q1 2022 | $158,000 | – | 180,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 89,152 | $76,268,000 | 5.41% |
| CAMDEN ASSET MANAGEMENT L P /CA | 64,461,000 | $54,550,000 | 1.83% |
| Penn Mutual Asset Management | 1,305,000 | $1,105,000 | 1.45% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 79,311,000 | $67,117,000 | 1.23% |
| ZAZOVE ASSOCIATES LLC | 9,978,000 | $8,481,000 | 0.77% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 29,500,000 | $25,112,000 | 0.46% |
| SHENKMAN CAPITAL MANAGEMENT INC | 8,279,000 | $7,014,000 | 0.39% |
| SSI INVESTMENT MANAGEMENT LLC | 5,833,000 | $4,936,000 | 0.33% |
| Lombard Odier Asset Management (Europe) Ltd | 6,266,000 | $5,334,000 | 0.28% |
| MACKAY SHIELDS LLC | 7,716,000 | $6,568,000 | 0.17% |